Sculptor Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 281 |
|
|
2023
Q4 | – | Sell |
-18,799
| Closed | -$1.66M | – | 301 |
|
|
2023
Q3 | $1.66M | Hold |
18,799
| – | – | 0.03% | 118 |
|
|
2023
Q2 | $1.63M | Hold |
18,799
| – | – | 0.03% | 120 |
|
|
2023
Q1 | $1.83M | Buy |
+18,799
| New | +$1.83M | 0.04% | 180 |
|
|
2020
Q2 | – | Sell |
-8,249
| Closed | -$697K | – | 197 |
|
|
2020
Q1 | $697K | Sell |
8,249
-24,670
| -75% | -$2.08M | 0.01% | 121 |
|
|
2019
Q4 | $2.78M | Buy |
32,919
+1,625
| +5% | +$137K | 0.03% | 117 |
|
|
2019
Q3 | $2.11M | Buy |
31,294
+9,294
| +42% | +$626K | 0.02% | 131 |
|
|
2019
Q2 | $1.88M | Buy |
+22,000
| New | +$1.88M | 0.01% | 132 |
|
|
2015
Q2 | – | Sell |
-596,794
| Closed | -$74.4M | – | 234 |
|
|
2015
Q1 | $74.4M | Buy |
+596,794
| New | +$74.4M | 0.24% | 66 |
|